The AACR and Eli Lilly and Company established this award in 1961 to honor Dr. G.H.A. Clowes, who was a founding member of the AACR and a research director of Eli Lilly. The Clowes Award recognizes an individual with outstanding recent accomplishments in basic cancer research.
The recipient of the AACR G.H.A. Clowes Memorial Award will receive an honorarium, give an award lecture during the AACR Annual Meeting 2020 in San Diego, California, USA, and will be given support for the winner and a guest to attend the Annual Meeting.
Responsibilities of the Award Winner
The winner must also attend the AACR Awards Reception and Program as well as the AACR G.H.A. Clowes Memorial Award Reception both of which will be held at the AACR Annual Meeting 2020.
Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry or government.
The award will be presented to an individual investigator.
Institutions or organizations are not eligible for the award.
Nominations may be submitted by any individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Self-nominations are prohibited.
Nominators must maintain strict confidentiality of their nominations and all nominations must be submitted electronically to https://myaacr.aacr.org. Paper nominations will not be accepted.
See the Program Guidelines and Nomination Instructions for complete details.
Candidates will be considered by a committee of international cancer leaders appointed by the president of the AACR. After careful deliberations by the Award Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the award winner will be made on the basis of the candidate’s recent accomplishments in basic cancer research. No regard will be given to age, race, gender, nationality, geographic location or religious or political views.